25 May 2013
Keywords: cortecs, boosted, sb, agreement, after, strategy, refocus
Article | 04 November 1999
UK firm Cortecs has received a boost with the news that SmithKlineBeecham has licensed exclusive rights to the former's antigen ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 November 1999
24 May 2013
© 2013 thepharmaletter.com